 10. Is not eligible for participation in any of the investigators ongoing clinical trials or has recently completed a clinical trial that has been terminated and, after considering other options for example., trial extensions, amendments, etc., the clinical team has determined that treatment is necessary and there are no other feasible alternatives for the patient 